We are so pleased to announce that Professor Rob Dineen has become the new Chair of the AT Society Scientific Advisory Board.
Rob is an academic and clinical neuroradiologist based in the Division of Clinical Neuroscience at the University of Nottingham. He has experience of leading on lots of AT scientific research projects and joins the SAB with a wealth of knowledge in this area.
The SAB exists to provide independent scientific advice to the AT Society on our research priorities. Members of the Board volunteer their time and expertise to ensure that we invest our funds in research as wisely as possible and in line with the charity’s mission.
Rob said:
“The SAB brings together independent scientists and clinicians specialising in a range of research areas of relevance to AT including Molecular Biology, Biochemistry, Immunology, Cancer Research, Clinical Pharmacology, Physiology, Neuroscience, Neurology and Genetics, as well as people with lived experience of AT. I look forward to working with this impressive group to help ensure that research funded and supported by the AT Society can continue its path of advancing our understanding of AT and improving treatments.”
For the next few years, the AT Society is primarily focusing its research efforts on understanding and treating the neurological problems caused by AT and the loss of the ATM protein. This is the feature of AT which has the greatest impact on everyday life for people with AT. Click here to see the research we are currently supporting.
